EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of Programmed Death‐Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features

Zahra Vahedpoor, Amirhasan Matini, Habibollah Rahimi iD, Majid Lotfinia, Hossein Motedayyen iD, Leyla Sadat Hejazi

Immunity, Inflammation and Disease · 2026-05 · 14 (5)

DOI: 10.1002/iid3.70464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 06.05.2026. Verfasst von Zahra Vahedpoor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, B7-H1 Antigen, Carcinoma, Squamous Cell, Adenocarcinoma. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputy of Research, Kashan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cervical cancer remains a significant global health challenge, with squamous cell carcinoma (SCC) and adenocarcinoma representing its predominant histologic types. Programmed death‐ligand 1 (PD‐L1) expression in cervical cancer has been implicated in tumor immune evasion, yet its prognostic significance remains unclear. This study aimed to evaluate PD‐L1 expression in cervical cancer and its association with clinicopathological features and patient survival.

Methods

This study included formalin‐fixed, paraffin‐embedded tissue samples from forty‐seven patients with cervical cancer. PD‐L1 expression was assessed by immunohistochemistry (IHC) and correlated with clinical data, HPV status (determined by p16 IHC and HPV DNA PCR/genotyping), and 2‐year survival outcomes. Statistical analyses included Fisher's exact test and Kaplan–Meier survival analysis.

Results

PD‐L1 was expressed in 61.2% of cases, predominantly in keratinizing SCC ( p = 0.006) and tumors with diffuse HPV positivity ( p < 0.001). PD‐L1 expression significantly correlated with advanced FIGO stage ( p = 0.03) but not with age, vascular invasion, and 2‐year survival. No significant survival difference was observed between PD‐L1 positive and negative groups.

Conclusions

PD‐L1 is frequently expressed in cervical carcinoma, especially keratinizing SCC and HPV‐diffuse tumors, but its expression was not associated with 2‐year survival. The heterogeneous expression and complex tumor‐immune interactions suggest that PD‐L1 alone is insufficient as a prognostic biomarker. Future research integrating additional immune and molecular markers is needed to improve prognostication and therapeutic stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsB7-H1 AntigenCarcinoma, Squamous CellAdenocarcinomaHumansFemaleMiddle AgedPrognosisHuman Papillomavirus VirusesAdultImmunohistochemistryBiomarkers, TumorAgedPapillomavirus InfectionsNeoplasm Staging

Stichwörter der Autor:innen

cervical cancerimmunohistochemistryprogrammed death‐ligand 1 (PD‐L1)squamous cell carcinoma

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
  • Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran.
  • Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran.
  • Department of Obstetrics and Gynecology, Kashan University of Medical Sciences, Kashan, Iran.

ORCID-Profile: Habibollah Rahimi, Hossein Motedayyen

Förderung

  • Deputy of Research, Kashan University of Medical Sciences

Zitieren

APA

Vahedpoor, Z., Matini, A., Rahimi, H., Lotfinia, M., Motedayyen, H., & Hejazi, L. S. (2026). Expression of Programmed Death‐Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features. Immunity, Inflammation and Disease, 14(5). https://doi.org/10.1002/iid3.70464

Vancouver

Vahedpoor Z, Matini A, Rahimi H, Lotfinia M, Motedayyen H, Hejazi LS. Expression of Programmed Death‐Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features. Immunity, Inflammation and Disease. 2026;14(5). doi:10.1002/iid3.70464

BibTeX
@article{Vahedpoor2026,
  author = {Vahedpoor, Zahra and Matini, Amirhasan and Rahimi, Habibollah and Lotfinia, Majid and Motedayyen, Hossein and Hejazi, Leyla Sadat},
  title = {Expression of Programmed Death‐Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {5},
  doi = {10.1002/iid3.70464}
}
Kostenlos starten →